Latest Paul Schimmel Stories

2014-05-21 08:29:06

First Demonstration of Safety and Tolerability of Physiocrines SAN DIEGO, May 21, 2014 /PRNewswire/ -- aTyr Pharma, an innovative rare disease therapeutics enterprise, announced today completion of Phase 1 for its lead program, Resokine IV. Our study, which marked the first ever administration of a Physiocrine to humans, was conducted in healthy male and female subjects in the European Union to assess the safety and tolerability of Resokine IV. aTyr Pharma is developing Resokine IV...

2014-03-28 08:26:48

SAN DIEGO, March 28, 2014 /PRNewswire/ -- aTyr Pharma ("aTyr"), a rare disease biotherapeutics enterprise, announced today the appointment of Ed Penhoet, Ph.D., to the Company's board of directors (BOD). Dr. Penhoet, who co-founded Chiron, is an accomplished scientist and biotech pioneer. He has served on the Independent Citizens Oversight Committee (ICOC) for the California Institute of Regenerative Medicine (CIRM) and was recently appointed to President Obama's Council of...

2014-02-24 08:28:17

First Administration to Human Subjects of a New Protein Class, Physiocrines SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- aTyr Pharma, a rare disease therapeutics enterprise, announced today the first administration of Resokine IV to healthy human volunteers. The study is being conducted in healthy male and female volunteers in the European Union. aTyr plans to develop Resokine IV as a potential therapeutic for rare disorders where a patient's immune system is imbalanced. Resokine belongs...

Secret Of Herbal Malaria Cure Unlocked
2012-12-24 11:17:14

redOrbit Staff & Wire Reports - Your Universe Online For over a millennium the Chinese have used an herb known as Chang Shan to treat fevers associated with malaria. While its effectiveness in treating the disease has long been confirmed by modern medicine, its exact function has remained mystery. However, in a recent study, scientists at The Scripps Research Institute (TSRI) say they have uncovered the molecular mechanism that gives this ancient homeopathic drug its healing...

2010-06-14 05:00:00

SAN DIEGO, June 14 /PRNewswire/ -- aTyr Pharma, Inc. today announced that Catharine E. Johnson, Ph.D. has recently joined the company as its Senior Vice President of Business Development. Dr. Johnson's extensive biotechnology industry experience will help to advance aTyr Pharma's portfolio of resectin-based therapeutics. Resectins are a novel class of endogenous human proteins derived from aminoacyl tRNA synthetases, and have activities relevant to multiple disease areas, including...

Word of the Day
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.